Literature DB >> 20359534

Blocking TRAIL-DR5 signaling with soluble DR5 reduces delayed neuronal damage after transient global cerebral ischemia.

Min Cui1, Limei Wang, Xiaohong Liang, Xuelian Ma, Yugang Liu, Mingfeng Yang, Kejing Liu, Xinbing Wei, Zhiqiang Zhou, Youhai H Chen, Wensheng Sun.   

Abstract

Mechanisms underlying delayed selective neuronal death after global cerebral ischemia remain to be clarified. Here, we report a critical role for tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) in the pathogenesis of cerebral ischemia. C57BL/6j mice were subjected to transient global brain ischemia. RT-PCR and immunohistochemistry showed that the expression of TRAIL and DR5 was upregulated following transient ischemia-reperfusion. Dual immunofluorescence analysis indicated that TRAIL expression was significantly more pronounced in astrocytes and activated microglia/macrophages, whereas DR5 expression was more pronounced in neurons, which had a good correlation with the distribution of apoptotic cells. Treatment with soluble DR5 reduced ischemic cell death after transient global ischemia through blocking the interaction of endogenous TRAIL with DR5. These results indicate that TRAIL plays a deleterious role in the pathogenesis of delayed neuronal damage after global cerebral ischemia and inhibition of TRAIL function in the brain may represent a novel neuroprotective strategy to treat ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20359534     DOI: 10.1016/j.nbd.2010.03.018

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  18 in total

1.  A new TRAIL in Alzheimer's disease therapy.

Authors:  Dan Frenkel
Journal:  Brain       Date:  2015-01       Impact factor: 13.501

2.  Modulator of apoptosis-1 is a potential therapeutic target in acute ischemic injury.

Authors:  Su Jing Chan; Hui Zhao; Kazuhide Hayakawa; Chou Chai; Chong Teik Tan; Jiawen Huang; Ran Tao; Gen Hamanaka; Thiruma V Arumugam; Eng H Lo; Victor Chun Kong Yu; PeterTsun-Hon Wong
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-22       Impact factor: 6.200

3.  The death-promoting molecule tumour necrosis factor-related apoptosis inducing ligand (TRAIL) is not required for the development of peripheral lymphopenia or granuloma necrosis during infection with virulent Mycobacterium avium.

Authors:  M Borges; G T Rosa; R Appelberg
Journal:  Clin Exp Immunol       Date:  2011-04-06       Impact factor: 4.330

4.  Remote Limb Preconditioning Generates a Neuroprotective Effect by Modulating the Extrinsic Apoptotic Pathway and TRAIL-Receptors Expression.

Authors:  Wei Xu; Wei Jin; Xiaoxiao Zhang; Jing Chen; Chuancheng Ren
Journal:  Cell Mol Neurobiol       Date:  2016-03-14       Impact factor: 5.046

5.  Blocking TRAIL-DR5 signaling with soluble DR5 alleviates acute kidney injury in a severely burned mouse model.

Authors:  Xiangfeng Leng; Qiu Zhang; Zhenyu Chen; Dechang Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

Review 6.  The immunology of stroke: from mechanisms to translation.

Authors:  Costantino Iadecola; Josef Anrather
Journal:  Nat Med       Date:  2011-07-07       Impact factor: 53.440

7.  Molecular mechanisms of neonatal brain injury.

Authors:  Claire Thornton; Catherine I Rousset; Anton Kichev; Yasuka Miyakuni; Regina Vontell; Ana A Baburamani; Bobbi Fleiss; Pierre Gressens; Henrik Hagberg
Journal:  Neurol Res Int       Date:  2012-01-26

Review 8.  Role of mitochondria in apoptotic and necroptotic cell death in the developing brain.

Authors:  Claire Thornton; Henrik Hagberg
Journal:  Clin Chim Acta       Date:  2015-02-04       Impact factor: 3.786

9.  Immunoprofiling of Nonarteritic Anterior Ischemic Optic Neuropathy.

Authors:  Louise A Mesentier-Louro; Laurel Stell; Yan Yan; Artis A Montague; Vinicio de Jesus Perez; Yaping Joyce Liao
Journal:  Transl Vis Sci Technol       Date:  2021-07-01       Impact factor: 3.048

10.  Immunological profile of silent brain infarction and lacunar stroke.

Authors:  Paola Sarchielli; Katiuscia Nardi; Davide Chiasserini; Paolo Eusebi; Michela Tantucci; Vittorio Di Piero; Marta Altieri; Carmine Marini; Tommasina Russo; Mauro Silvestrini; Isabella Paolino; Paolo Calabresi; Lucilla Parnetti
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.